NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Clinical Guideline Centre – Acute and Chronic Conditions (UK). Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted to Hospital. London: Royal College of Physicians (UK); 2010. (NICE Clinical Guidelines, No. 92.)

Cover of Venous Thromboembolism

Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted to Hospital.

Show details

Appendix BDeclarations of interests

1.1. Introduction

All members of the GDG and all members of the NCC-AC staff were required to make formal declarations of interest at the outset, and these were updated at every subsequent meeting throughout the development process. No interests were declared that required action.

1.2. Declarations of interests of the GDG members

1.2.1. Tom Treasure (Chair)

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)None
Second GDG Meeting (29th October 2007)None
Third GDG Meeting (28th November 2007)None
Fourth GDG Meeting (9th January 2008)None
Fifth GDG Meeting (21st February 2008)None
Sixth GDG Meeting (2nd April 2008)None
Seventh GDG Meeting (13th May 2008)None
Eight GDG Meeting (27th June 2008)None
Ninth GDG Meeting (2nd September 2008)None
Tenth GDG Meeting (8th October 2008)None
Eleventh GDG Meeting (14th November 2008)None
Twelfth GDG Meeting (16th December 2008)Not attended
Thirteenth GDG Meeting (18th May 2009)None
Fourteenth GDG Meeting (8th July 2009)None
Fifteenth GDG meeting (3rd November 2009)None

1.2.2. Kim Carter

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)KC declared no personal pecuniary interest. She declared that she knew of no personal family interest. KC declared a non-personal pecuniary interest; the Trust that she works for has received a grant from Sanofi Aventis to develop a computerised assessment tool for VTE. Additionally she is a director of the Lifeblood Charity which receives some donations from the pharmaceutical industry. This is not a paid position. She declared a personal non-pecuniary interest; she is a member of Thrombosis Committee at Portsmouth Hospitals NHS Trust and has helped develop Trust VTE guidelines.
Second GDG Meeting (29th October 2007)No change to declarations
Third GDG Meeting (28th November 2007)KC declared that she knew of no personal pecuniary interest, personal family interest or personal non-pecuniary interest. She declared a non-personal pecuniary interest; the thrombosis committee at Portsmouth Hospitals Trust, of which she is a member, was nominated for, and was runner up at the hospital doctor team of the year award for thrombosis prophylaxis. The award was sponsored by Sanofi.
Fourth GDG Meeting (9th January 2008)No change to declarations
Fifth GDG Meeting (21st February 2008)No change to declarations
Sixth GDG Meeting (2nd April 2008)Not attended
Seventh GDG Meeting (13th May 2008)No change to declarations
Eight GDG Meeting (27th June 2008)No change to declarations
Ninth GDG Meeting (2nd September 2008)No change to declarations
Tenth GDG Meeting (8th October 2008)No change to declarations
Eleventh GDG Meeting (14th November 2008)No change to declarations
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)Not attended
Fourteenth GDG Meeting (8th July 2009)Not attended
Fifteenth GDG meeting (3rd November 2009)No change to declarations

1.2.3. Nandam Gautam

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)NG declared a personal pecuniary interest; he was paid to give Bristol-Myers Squibb lectures on unstable coronary syndrome. He declared that he knew of no personal family interest. NG declared a non-personal pecuniary interest; his unit received money from Sanofi Aventis for a short term DVT audit nurse. He declared a person non-pecuniary interest; he has established local policy guideline.
Second GDG Meeting (29th October 2007)No change to declarations
Third GDG Meeting (28th November 2007)Not attended
Fourth GDG Meeting (9th January 2008)No change to declarations
Fifth GDG Meeting (21st February 2008)NG declared a non-personal pecuniary interest, Bristol-Myers Squibb have donated £200 to an academic fund of which he is a director but not an exclusive cheque writer. He declared that he knew of no personal pecuniary, personal family interest or personal non-pecuniary interest above those already declared.
Sixth GDG Meeting (2nd April 2008)No change to declarations
Seventh GDG Meeting (13th May 2008)Not attended
Eight GDG Meeting (27th June 2008)No change to declarations
Ninth GDG Meeting (2nd September 2008)Not attended
Tenth GDG Meeting (8th October 2008)Not attended
Eleventh GDG Meeting (14th November 2008)NG declared a personal non-pecuniary interest. The department of acute medicine had a meeting sponsored by Bristol Myers Squibb. No financial benefit was gained. He declared he know of no personal pecuniary interest, personal family interest or non-personal pecuniary interest.
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)Not attended
Fourteenth GDG Meeting (8th July 2009)Not attended
Fifteenth GDG meeting (3rd November 2009)Not attended

1.2.4. Aroon Hingorani

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)AH declared a personal pecuniary interest; he is on the editorial board of Drug and Therapeutics Bulletin. He holds a Medical Research Council project grant with Pfizer as a collaborating co-funder. He has receives fellowship funding from British Heart Foundation. Has received honoraria for speaking at educational meetings (donated in full to charity). He declared that he knew of no personal family interest, non-personal pecuniary interest or personal non-pecuniary interest.
Second GDG Meeting (29th October 2007)No change to declarations
Third GDG Meeting (28th November 2007)No change to declarations
Fourth GDG Meeting (9th January 2008)No change to declarations
Fifth GDG Meeting (21st February 2008)Not attended
Sixth GDG Meeting (2nd April 2008)Not attended
Seventh GDG Meeting (13th May 2008)No change to declarations
Eight GDG Meeting (27th June 2008)No change to declarations
Ninth GDG Meeting (2nd September 2008)Not attended
Tenth GDG Meeting (8th October 2008)Not attended
Eleventh GDG Meeting (14th November 2008)Not attended
Twelfth GDG Meeting (16th December 2008)Not attended
Thirteenth GDG Meeting (18th May 2009)Not attended
Fourteenth GDG Meeting (8th July 2009)Not attended
Fifteenth GDG meeting (3rd November 2009)Not attended

1.2.5. Rodney Hughes

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)None
Second GDG Meeting (29th October 2007)None
Third GDG Meeting (28th November 2007)None
Fourth GDG Meeting (9th January 2008)RH declared a non-personal pecuniary interest; his unit is involved in a trial where Sanofi-Aventis are reimbursing the cost of the drugs, although no grant is provided. He declared that he knew of no personal pecuniary interest, personal family interest or personal non-pecuniary interest.
Fifth GDG Meeting (21st February 2008)No change to declarations
Sixth GDG Meeting (2nd April 2008)No change to declarations
Seventh GDG Meeting (13th May 2008)Not attended
Eight GDG Meeting (27th June 2008)No change to declarations
Ninth GDG Meeting (2nd September 2008)No change to declarations
Tenth GDG Meeting (8th October 2008)Not attended
Eleventh GDG Meeting (14th November 2008)No change to declarations
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)Not attended
Fourteenth GDG Meeting (8th July 2009)Not attended
Fifteenth GDG meeting (3rd November 2009)No change to declarations

1.2.6. Beverley Hunt

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)BH declared a personal pecuniary interest; she has been paid for giving lectures and taking part in drug advisory boards for Sanofi Aventis, Bayer and Boehringer Ingelheim within the last 12 months. She has been paid to script write and story board a set of cartoons on coagulation and VTE. She has attended a meeting which was funded by Bayer with journalists to develop user friendly words about VTE. She declared that she knew of no personal family interest. She declared a non-personal pecuniary interest; she is a director of British Society for Haematology Ltd and a director of Lifeblood, the Thrombosis Charity Ltd which receives money donated from industry for set projects. This is not a paid position. BH declared a personal non-pecuniary interest; she will appear before Health Select Committee on 18th October for a discussion about NICE processes.
Second GDG Meeting (29th October 2007)BH declared a personal pecuniary interest; she has received a grant to her research funds from Bayer to pay for flights to attend the American Society of Haematology meeting in December 2007. She declared a non-personal pecuniary interest; a contribution to Lifeblood: the thrombosis charity was made in return for attending a meeting with journalists to discuss VTE terminology. She declared that she knew of no personal family interest or personal non-pecuniary interest above those she declared at the previous meeting.
Third GDG Meeting (28th November 2007)No change to declarations
Fourth GDG Meeting (9th January 2008)BH declared a non-personal pecuniary interest, meeting on 10 January 2008 organised by Bayer to discuss how to set-up thrombosis committees in trusts for which Lifeblood will receive payment. She declared that she knew of no personal pecuniary, personal family interest, non-personal pecuniary interest or personal non-pecuniary interest.
Fifth GDG Meeting (21st February 2008)BH declared a non-personal pecuniary interest, Lifeblood for which she is a trustee has received educational grants from Bayer and Boehringer Ingelheim to develop the website. She declared a personal non-pecuniary interest, lecturing at a symposium at the British Society for haematology sponsored by Boehringer Ingelheim in April 2008, for which the fee was given to Lifeblood. She declared that she knew of no personal pecuniary interest or personal family interest above those declared at the previous meeting.
Sixth GDG Meeting (2nd April 2008)No change to declarations
Seventh GDG Meeting (13th May 2008)BH declared a personal non-pecuniary interest; she gave media interviews for the launch of Dabigaran to BBC, ITN, Radio 5 Live and Sky giving an independent view. During the media day the PR company working for Boehringer Ingelheim produced a press release on the Lifeblood s behalf without agreement from them. Lifeblood have made a formal complaint to The Association of the British Pharmaceutical Industry (ABPI), the Medicines and Healthcare products Regulatory Agency (MHRA) and NICE have been copied in. BH did not declare a personal pecuniary interest, personal family interest or non-personal pecuniary interests above those declared at the previous meeting.
Eight GDG Meeting (27th June 2008)No change to declarations
Ninth GDG Meeting (2nd September 2008)BH declared a non-personal pecuniary interest; Lifeblood: the thrombosis charity received money from Bayer for a lecture that she gave to journalists on VTE. She declared that she knew of no personal pecuniary interest, family interest or personal non-pecuniary interest, above those declared at the previous meeting.
Tenth GDG Meeting (8th October 2008)No change to declarations
Eleventh GDG Meeting (14th November 2008)BH declared a non-personal pecuniary interest; she was sponsored by Bayer to give a talk, monies received were given to Lifeblood, the thrombosis charity. She declared she knew of no personal pecuniary interest, personal family interest or personal non-pecuniary interest above those declared at the previous meeting.
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)No change to declarations
Fourteenth GDG Meeting (8th July 2009)No change to declarations
Fifteenth GDG meeting (3rd November 2009)BH declared a non-personal pecuniary interest; she accepted travel expenses for running a meeting for LGO and gave the remaining fee to charity. She declared that she knew of personal pecuniary interest, personal family interest or personal non-pecuniary interest, above those declared at the previous meeting.

1.2.7. Nigel Langford

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)NL declared a personal pecuniary interest; he received an honorarium from the University of Birmingham for lecturing on anticoagulation courses. He declared that he knew of no personal family interest. He declared a non-personal pecuniary interest; his department has received a grant into research looking at cellulitis as well as a service evaluation into the nurse led DVT/PE service from Sanofi Aventis. He declared a personal non-pecuniary interest; he is a member of a thrombosis committee, and has had a paper on venometers published in Acute Medicine.
Second GDG Meeting (29th October 2007)NL declared a non-personal pecuniary interest; his unit received a gift of single use tourniquets from Sanofi Aventis for an audit project. He declared he knew of no other personal pecuniary interest, personal family interest, non-personal pecuniary interest or personal non-pecuniary interest, above those he declared at the previous meeting
Third GDG Meeting (28th November 2007)No change to declarations
Fourth GDG Meeting (9th January 2008)Not attended
Fifth GDG Meeting (21st February 2008)No change to declarations
Sixth GDG Meeting (2nd April 2008)No change to declarations
Seventh GDG Meeting (13th May 2008)No change to declarations
Eight GDG Meeting (27th June 2008)No change to declarations
Ninth GDG Meeting (2nd September 2008)No change to declarations
Tenth GDG Meeting (8th October 2008)No change to declarations
Eleventh GDG Meeting (14th November 2008)No change to declarations
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)Not attended
Fourteenth GDG Meeting (8th July 2009)Not attended
Fifteenth GDG Meeting (3rd November 2009)No change to declarations

1.2.8. Donald McBride (Joined the main guideline development group in Sep 2008)

GDG meetingDeclaration of Interests
Ninth GDG Meeting (2nd September 2008)None
Tenth GDG Meeting (8th October 2008)None
Eleventh GDG Meeting (14th November 2008)None
Twelfth GDG Meeting (16th December 2008)None
Thirteenth GDG Meeting (18th May 2009)None
Fourteenth GDG Meeting (8th July 2009)None
Fifteenth GDG meeting (3rd November 2009)None

1.2.9. Gordon McPherson (Resigned from the guideline development group in Feb 2008)

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)None
Second GDG Meeting (29th October 2007)None
Third GDG Meeting (28th November 2007)Not attended
Fourth GDG Meeting (9th January 2008)Not attended
Mr Gordon McPherson resigned from the GDG in Feburary 2008. He was replaced by Mr Peter Walton

1.2.10. Paul Mainwaring

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)None
Second GDG Meeting (29th October 2007)None
Third GDG Meeting (28th November 2007)Not attended
Fourth GDG Meeting (9th January 2008)Not attended
Fifth GDG Meeting (21st February 2008)Not attended
Sixth GDG Meeting (2nd April 2008)None
Seventh GDG Meeting (13th May 2008)Not attended
Eight GDG Meeting (27th June 2008)Not attended
Ninth GDG Meeting (2nd September 2008)PM declared a personal non-pecuniary interest; he has been involved in running focus groups for several PCTs to look at world class commissioning and some of the pathways involved around: A&E redesign, Community Based Anticoagulation Monitoring Service, Community Chronic Kidney Disease Service, Community Dermatology Service
He declared that he knew of no personal pecuniary interest, family interest or personal non-pecuniary interest, above those declared at the previous meeting.
Tenth GDG Meeting (8th October 2008)Not attended
Eleventh GDG Meeting (14th November 2008)Not attended
Twelfth GDG Meeting (16th December 2008)Not attended
Thirteenth GDG Meeting (18th May 2009)Not attended
Fourteenth GDG Meeting (8th July 2009)Not attended
Fifteenth GDG meeting (3rd November 2009)Not attended

1.2.11. Simon Noble

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)SN declared a personal pecuniary interest; he received honoraria from Leo Pharma for a talk given from in October 2006, and from Sanofi Aventis for a talk given in June 2006. He declared that he knew of no personal family interest. He declared a non-personal pecuniary interest; he is a grant holder (but not administrator/manager) for a study of dalteparin on lung cancer $1,000,000 from Pfizer. He declared that he knew of no personal non-pecuniary interest.
Second GDG Meeting (29th October 2007)SN declared a personal non-pecuniary interest; he has been involved with the Welsh Assembly on a committee to promote safe prevention of VTE in association with Lifeblood. He declared he knew of no other personal pecuniary interest, personal family interest, non-personal pecuniary interest or personal non-pecuniary interest, above those he declared at the previous meeting.
Third GDG Meeting (28th November 2007)No change to declarations
Fourth GDG Meeting (9th January 2008)SN declared a non-personal pecuniary interest; he has accepted and invitation to become a trustee of Lifeblood. He declared that he knew of no personal pecuniary interest, personal family interest or personal non-pecuniary interest.
Fifth GDG Meeting (21st February 2008)No change to declarations
Sixth GDG Meeting (2nd April 2008)No change to declarations
Seventh GDG Meeting (13th May 2008)No change to declarations
Eight GDG Meeting (27th June 2008)Not attended
Ninth GDG Meeting (2nd September 2008)SN declared a personal non-pecuniary interest; he has been invited to be a member of a thromboprophylaxis forum, supported by an unrestricted educational grant from Boerhinger Ingelheim. He declared that he knew of no personal pecuniary interest, personal family interest or non-personal pecuniary interest, above those declared at the previous meeting.
Tenth GDG Meeting (8th October 2008)No change to declarations
Eleventh GDG Meeting (14th November 2008)Not attended
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)No change to declarations
Fourteenth GDG Meeting (8th July 2009)No change to declarations
Fifteenth GDG meeting (3rd November 2009)Not attended

1.2.12. Gerard Stansby

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)GS declared a personal pecuniary interest; he has received speaker s fees from Sanofi Aventis and Bristol-Myers Squibb for chairing and speaking at meetings on peripheral arterial disease. He declared that he knew of no personal family interest. GS declared a non-personal pecuniary interest; he is co-chair of TARGET- PAD a lobbying group for peripheral arterial disease which is sponsored by Bristol- Myers Squibb. GS declared a personal non-pecuniary interest; he is an author on Cochrane review on combined therapies for DVT prophylaxis (not yet published).
Second GDG Meeting (29th October 2007)No change to declarations
Third GDG Meeting (28th November 2007)No change to declarations
Fourth GDG Meeting (9th January 2008)No change to declarations
Fifth GDG Meeting (21st February 2008)No change to declarations
Sixth GDG Meeting (2nd April 2008)No change to declarations
Seventh GDG Meeting (13th May 2008)No change to declarations
Eight GDG Meeting (27th June 2008)No change to declarations
Ninth GDG Meeting (2nd September 2008)No change to declarations
Tenth GDG Meeting (8th October 2008)No change to declarations
Eleventh GDG Meeting (14th November 2008)No change to declarations
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)No change to declarations
Fourteenth GDG Meeting (8th July 2009)No change to declarations
Fifteenth GDG meeting (3rd November 2009)No change to declarations

1.2.13. Peter Walton (Joined the guideline development group in Feb 2008)

GDG meetingDeclaration of Interests
Peter Walton was recruited to the GDG in February 2008 to replace Mr. Gordon McPherson as patient representative.
Fifth GDG Meeting (21st February 2008)None
Sixth GDG Meeting (2nd April 2008)None
Seventh GDG Meeting (13th May 2008)None
Eight GDG Meeting (27th June 2008)None
Ninth GDG Meeting (2nd September 2008)None
Tenth GDG Meeting (8th October 2008)None
Eleventh GDG Meeting (14th November 2008)None
Twelfth GDG Meeting (16th December 2008)None
Thirteenth GDG Meeting (18th May 2009)Not attended
Fourteenth GDG Meeting (8th July 2009)Not attended
Fifteenth GDG meeting (3rd November 2009)None

1.2.14. Annie Young

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)None
Second GDG Meeting (29th October 2007)AY declared a personal pecuniary interest; she was paid by GlaxoSmithKline to attend the European Cancer Nursing Advisory Board in September 2007. She declared a personal non-pecuniary interest; she is the President of the UK Oncology Nursing Society which is supported by pharmaceutical companies. She declared she knew of no personal family interest or non-personal pecuniary interest above those she declared at the previous meeting.
Third GDG Meeting (28th November 2007)No change to declarations
Fourth GDG Meeting (9th January 2008)No change to declarations
Fifth GDG Meeting (21st February 2008)AY declared a non-personal pecuniary interest; she has been invited onto the National Collaborating Centre for Cancer management group for cancer drugs. She declared that she knew of no personal pecuniary interest, personal family interest or non-personal pecuniary interests, above those declared at the previous meeting.
Sixth GDG Meeting (2nd April 2008)AY declared a personal pecuniary interest; she will be writing for travel grant to attend International Society of Nurses in Cancer Care (ISNCC) meeting in August in Singapore. She did not declare a personal family interest, non-personal pecuniary interest or personal non-pecuniary interest, above those declared at the previous meeting.
Seventh GDG Meeting (13th May 2008)No change to declarations
Eight GDG Meeting (27th June 2008)No change to declarations
Ninth GDG Meeting (2nd September 2008)AY declared a personal pecuniary interest; she received a travel grant from 10 pharmaceutical companies for herself and 5 nurses to attend the society of nurses in cancer care conference. She declared that she knew of no personal family interest, non-personal pecuniary interest or personal non-pecuniary interest, above those declared at the previous meeting.
Tenth GDG Meeting (8th October 2008)No change to declarations
Eleventh GDG Meeting (14th November 2008)Not attended
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)No change to declarations
Fourteenth GDG Meeting (8th July 2009)AY declared travelling expenses to MASCC meeting (Multiagency in Supportive Cancer Care) Rome 24th June 2009 GSK paid for.
Fifteenth GDG meeting (3rd November 2009)AY declared a personal pecuniary interest; she recieved travel expenses to ECCO Berlin from GSK, as well as travel and accommodation expenses to attend a conference in Brighton from MSD and Pfizer. AY declared a personal non-pecuniary interest: she participated at the NCRI conference and Thrombosis and Cancer workshop (no fee received). She declared that she knew of no personal family interest, or non-personal pecuniary interest, above those declared at the previous meeting.

1.2.15. Declarations of interests of the NCC-AC members

GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)JH, DW, CS declared they worked on the 1st VTE guildeline.
Second GDG Meeting (29th October 2007)None
Third GDG Meeting (28th November 2007)None
Fourth GDG Meeting (9th January 2008)None
Fifth GDG Meeting (21st February 2008)None
Sixth GDG Meeting (2nd April 2008)None
Seventh GDG Meeting (13th May 2008)None
Eight GDG Meeting (27th June 2008)None
Ninth GDG Meeting (2nd September 2008)None
Tenth GDG Meeting (8th October 2008)None
Eleventh GDG Meeting (14th November 2008)None
Twelfth GDG Meeting (16th December 2008)None
Thirteenth GDG Meeting (18th May 2009)None
Fourteenth GDG Meeting (8th July 2009)None
Fifteenth GDG meeting (3rd November 2009)None

1.3. Declarations of interests of the Orthopaedic Subgroup Members

1.3.1. Tom Treasure (Chair)

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)None
Second GDG Meeting (30th July 2008)None
Third GDG Meeting (17th October 2007)None
Fourth GDG Meeting (9th January 2009)None
Fifth GDG Meeting (22nd May 2009)None

1.3.2. Kim Carter

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)None
Second GDG Meeting (30th July 2008)None
Third GDG Meeting (17th October 2007)None
Fourth GDG Meeting (9th January 2009)None
Fifth GDG Meeting (22nd May 2009)None

1.3.3. Simon Carter

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)None
Second GDG Meeting (30th July 2008)None
Third GDG Meeting (17th October 2007)None
Fourth GDG Meeting (9th January 2009)None
Fifth GDG Meeting (22nd May 2009)Not attended

1.3.4. Nick Fiddian

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)None
Second GDG Meeting (30th July 2008)None
Third GDG Meeting (17th October 2007)Not attended
Fourth GDG Meeting (9th January 2009)None
Fifth GDG Meeting (22nd May 2009)Not attended

1.3.5. Simon Frostick

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)SF declared a personal pecuniary interest; he received an honorarium from Boehringer Ingelheim. He declared a non-personal pecuniary interest; he has received funds from Bayer. He declared that he knew of no personal family interest or personal non-pecuniary interest.
Second GDG Meeting (30th July 2008)No change to declarations
Third GDG Meeting (17th October 2007)No change to declarations
Fourth GDG Meeting (9th January 2009)No change to declarations
Fifth GDG Meeting (22nd May 2009)Not attended

1.3.6. Paul Gregg

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)None
Second GDG Meeting (30th July 2008)None
Third GDG Meeting (17th October 2007)None
Fourth GDG Meeting (9th January 2009)PG declared he knew of no personal pecuniary interest, personal non-pecuniary interest, personal family interest, but indicated that he took part in a debate and received funds from Boerhinger Ingelheim.
Fifth GDG Meeting (22nd May 2009)Not attended

1.3.7. Donald McBride

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)None
Second GDG Meeting (30th July 2008)Not attended
Third GDG Meeting (17th October 2007)Not attended
Fourth GDG Meeting (9th January 2009)None
Fifth GDG Meeting (22nd May 2009)None

1.3.8. David Warwick

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)DWk declared a personal pecuniary interest; he has received payments from Sanofi Aventis to lecture (April 2008), Boehringer Ingelheim to lecture (May 2008), Johnson & Johnson Registry to participate in Advisory Boards (May 2008 - ongoing), Ramsey Healthcare to review VTE guidelines. He declared that he knew of no personal family interest or non-personal pecuniary interest. He declared a personal non-pecuniary interest; he has published in the journal of bone and joint surgery (Insufficient duration of venous thromboemolism prophylaxis June 2007, Orthopaedic thromboprophylaxis limitations of current guidelines Feb 2008).
Second GDG Meeting (30th July 2008)No change to declarations
Third GDG Meeting (17th October 2007)No change to declarations
Fourth GDG Meeting (9th January 2009)No change to declarations
Fifth GDG Meeting (22nd May 2009)No change to declarations

1.3.9. Nick Welch

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)Not attended
Second GDG Meeting (30th July 2008)NW declared personal non-pecuniary interest; he worked for 36 years in the pharmaceutical industry prior to retirement. This included 18 years with Boehringer Ingelheim. He declared he knew of no personal pecuniary interest, personal family interest, non-personal pecuniary interest.
Third GDG Meeting (17th October 2007)Not attended
Fourth GDG Meeting (9th January 2009)No change to declarations
Fifth GDG Meeting (22nd May 2009)No change to declarations

1.3.10. Claire Young

GDG meetingDeclaration of Interests
First GDG meeting (2nd June 2008)None
Second GDG Meeting (30th July 2008)None
Third GDG Meeting (17th October 2007)None
Fourth GDG Meeting (9th January 2009)None
Fifth GDG Meeting (22nd May 2009)None

1.4. Declarations of interests of expert advisors

1.4.1. David Fitzmaurice (General practitioner post-discharge prophylaxis)

DOI DateDeclaration of Interests
25th November 2008DF declared personal pecuniary interests: he has attended advisory board meetings for Bayer, Boehringer Ingelheim and would be attending board meeting for Sanofi Aventis.

1.4.2. Ian A Greer (Dean of medical school -- Pregnancy and postpartum)

DOI DateDeclaration of Interests
22nd May 2009IG declared personal pecuniary interests: he has received honoraria for speaking at conferences and for advisory boards from Leo Pharma and Sanofi Aventis

1.4.3. Nihal Gurusinghe (Neurosurgeon Neurosurgery and spinal surgery)

DOI DateDeclaration of Interests
1st December 2008None

1.4.4. Mike Laffan (Haematologist Pregnancy and postpartum)

DOI DateDeclaration of Interests
24th May 2009None

1.4.5. Lucy Mackillop (Obstetric physician Pregnancy and postpartum)

DOI DateDeclaration of Interests
26th May 2009LM declared a personal non-pecuniary interest: She was the co-author of the Royal College of Obstetricians Gynaecologists guidelines on thromboprophylaxis which was due to be published in November 2009.

1.4.6. Peter McCallum (Haematologist Pregnancy and postpartum)

DOI DateDeclaration of Interests
25th May 2009PM declared personal pecuniary interests: he has received honorarium for lecturing from Pfizer, and paid honorarium for an advisory board meeting by Boehringer Ingelheim. He also declared non-personal pecuniary interest: his unit received funding from Boehringer Ingelheim to participate in a clinical trial of dabigatran in which he was a principal investigator. PM declared personal non-pecuniary interest: he was the co-author of guidelines that were being written for the Royal College of Obstetricians and Gynaecologists on reducing the risk of thromboembolism during pregnancy, birth and the puerperium.

1.4.7. Catherine Nelson-Piercy (Obstetric physician Pregnancy and postpartum)

DOI DateDeclaration of Interests
22nd May 2009None

1.4.8. Douglas Wardlaw (Neurosurgery Neurosurgery and other orthopaedic surgery)

DOI DateDeclaration of Interests
6th July 2007D Wardlaw declared personal non-pecuniary interests: he has a research interest in the topic and had papers accepted for publication in the European Spine Journal.
Copyright © 2010, National Clinical Guideline Centre - Acute and Chronic Conditions.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre - Acute and Chronic Conditions to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

Bookshelf ID: NBK116515

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (12M)
  • Disable Glossary Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...